BSE Live
Oct 01, 16:01Prev. Close
485.90
Open Price
485.90
Bid Price (Qty.)
486.20 (1)
Offer Price (Qty.)
493.50 (1)
NSE Live
Oct 01, 15:15Prev. Close
486.50
Open Price
486.50
Bid Price (Qty.)
487.95 (22)
Offer Price (Qty.)
488.40 (19)
Balance Sheet of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
Total Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
Reserves and Surplus | 1,160.08 | 1,083.27 | 1,021.70 | 879.57 | 766.41 | |
Total Reserves and Surplus | 1,160.08 | 1,083.27 | 1,021.70 | 879.57 | 766.41 | |
Total Shareholders Funds | 1,251.35 | 1,175.21 | 1,114.30 | 972.17 | 859.61 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 237.95 | 238.26 | 161.89 | 118.33 | 147.56 | |
Deferred Tax Liabilities [Net] | 73.26 | 69.73 | 68.37 | 70.04 | 74.97 | |
Other Long Term Liabilities | 1.01 | 1.08 | 12.84 | 11.44 | 10.85 | |
Long Term Provisions | 3.44 | 2.74 | 7.11 | 7.86 | 22.12 | |
Total Non-Current Liabilities | 315.65 | 311.81 | 250.20 | 207.67 | 255.50 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 275.97 | 234.60 | 371.20 | 396.55 | 142.18 | |
Trade Payables | 373.11 | 393.29 | 419.01 | 416.19 | 293.04 | |
Other Current Liabilities | 53.51 | 55.18 | 38.16 | 39.35 | 85.40 | |
Short Term Provisions | 3.20 | 1.53 | 2.63 | 2.59 | 1.28 | |
Total Current Liabilities | 705.79 | 684.60 | 830.99 | 854.68 | 521.89 | |
Total Capital And Liabilities | 2,272.79 | 2,171.62 | 2,195.50 | 2,034.52 | 1,637.01 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 761.12 | 722.08 | 634.17 | 649.35 | 630.41 | |
Intangible Assets | 0.12 | 0.21 | 0.31 | 0.07 | 0.11 | |
Capital Work-In-Progress | 273.40 | 221.62 | 160.75 | 59.62 | 15.95 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,034.63 | 943.92 | 795.23 | 709.03 | 646.47 | |
Non-Current Investments | 42.40 | 29.97 | 28.62 | 28.03 | 24.32 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 15.20 | 16.71 | 22.11 | 24.26 | 6.09 | |
Total Non-Current Assets | 1,092.23 | 990.60 | 845.96 | 761.33 | 676.88 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 407.23 | 441.77 | 477.73 | 488.46 | 390.38 | |
Trade Receivables | 701.72 | 643.95 | 801.68 | 711.64 | 503.99 | |
Cash And Cash Equivalents | 4.57 | 3.82 | 2.68 | 2.21 | 3.81 | |
Short Term Loans And Advances | 0.13 | 0.19 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 66.90 | 91.29 | 67.45 | 70.88 | 61.96 | |
Total Current Assets | 1,180.56 | 1,181.02 | 1,349.53 | 1,273.19 | 960.13 | |
Total Assets | 2,272.79 | 2,171.62 | 2,195.50 | 2,034.52 | 1,637.01 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 280.63 | 266.61 | 258.17 | 194.24 | 152.85 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 42.40 | 823.86 | 908.22 | 861.20 | 752.42 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 2.67 | 6.00 | 8.44 | 0.79 | 4.97 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 12.17 | 8.72 | 18.56 | 12.21 | 12.71 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 675.77 | 672.84 | 853.64 | 775.37 | 600.09 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 87.02 | 87.02 | 87.02 | 87.02 | 87.59 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 42.40 | 29.97 | 28.62 | 28.03 | 24.32 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
21.07.2025
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y
07.05.2025